Peptide YY, neuropeptide Y and corticotrophin-releasing factor modulate gastrointestinal motility and food intake during acute stress

Neurogastroenterology and Motility

Volumn 26, Issue 11, 2014, Pages 1605-1614

  Forbes, Sarah C ^a   Cox, Helen M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acute stress; Corticotrophin releasing factor; Food intake; Gastrointestinal and colonic function; Neuropeptide Y; Peptide YY

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; PEPTIDE YY;

ANIMAL; C57BL MOUSE; EXERCISE; FEEDING BEHAVIOR; GASTROINTESTINAL MOTILITY; KNOCKOUT MOUSE; MENTAL STRESS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; FEEDING BEHAVIOR; GASTROINTESTINAL MOTILITY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; PEPTIDE YY; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

EID: 84907868598     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12428     Document Type: Article

References (37)

1. Thorsell A. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp Biol Med 2010; 235: 1163-7.
2. Sah R, Ekhator NN, Strawn JR, Sallee FR, Baker DG, Horn PS, Geracioti TD Jr. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry 2009; 66: 705-7.
3. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC etal. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008; 452: 997-8.
4. Thorsell A, Carlsson K, Ekman R, Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. NeuroReport 1999; 10: 3003-7.
5. Morgan CA, Wang S, Southwick SM, Rasmusson A, Hazlett G, Hauger RL, Charney DS. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry 2000; 47: 902-9.
6. Onaga T, Zabielski R, Kato S. Multiple regulation of peptide YY secretion in the digestive tract. Peptides 2002; 23: 279-90.
7. Painsipp E, Herzog H, Sperk G, Holzer P. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br J Pharmacol 2011; 163: 1302-14.
8. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 2012; 46: 261-74.
9. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T etal. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998; 50: 143-50.
10. Rao SSC, Hatfield RA, Suls JM, Chamberlain MJ. Psychological and physical stress induce differential effects on human colonic motility. Am J Gastroenterol 1998; 93: 985-90.
11. Martinez V, Wang L, Rivier J, Grigoriadis D, Tache Y. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice (vol 556, pg 221, 2004). J Physiol 2004; 556: 1013-1013.
12. Forbes S, Herzog H, Cox HM. A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. Br J Pharmacol 2012; 166: 2307-16.
13. Tebbe JJ, Mronga S, Tebbe CG, Ortmann E, Arnold R, Schafer MKH. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y-1- and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 2005; 17: 570-6.
14. Tache Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004; 16: 137-42.
15. Million M, Wang L, Stenzel-Poore MP, Coste SC, Yuan PQ, Lamy C, Rivier J, Buffington T etal. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1429-38.
16. Wang L, Gourcerol G, Yuan P-Q, Wu SV, Million M, Larauche M, Taché Y. Peripheral peptide YY inhibits propulsive colonic motor function through Y-2 receptor in conscious mice. Am J Physiol Gastrointest Liver Physiol 2010; 298: G45-56.
17. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of Peptide YY (PYY) on mouth to cecum intestinal transit-time and on the rate of gastric emptying in healthy volunteers. Gut 1987; 28: 166-70.
18. Tough IR, Forbes S, Tolhurst R, Ellis M, Herzog H, Bornstein JC, Cox HM. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y-1 and Y-2 receptors. Br J Pharmacol 2011; 164: 471-84.
19. Sekino A, Ohata H, Mano-Otagiri A, Arai K, Shibasaki T. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology 2004; 176: 30-8.
20. Calvez J, Fromentin G, Nadkarni N, Darcel N, Even P, Tomé D, Ballet N, Chaumontet C. Inhibition of food intake induced by acute stress in rats is due to satiation effects. Physiol Behav 2011; 104: 675-83.
21. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE etal. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 2002; 418: 650-4.
22. Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, Couzens M, Slack K etal. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 2006; 49: 1360-70.
23. Karl T, Duffy L, Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci 2008; 28: 173-80.
24. Edelsbrunner ME, Herzog H, Holzer P. Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res 2009; 203: 97-107.
25. Martinez V, Wang LX, Rivier JE, Vale W, Tache Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 2002; 301: 611-7.
26. Ducottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 625-31.
27. Pol O, Sasaki M, Jimenez N, Dawson VL, Dawson TM, Puig MM. The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice. Br J Pharmacol 2005; 145: 758-66.
28. Liang C, Luo H, Liu Y, Cao J, Xia H. Plasma hormones facilitated the hypermotility of the colon in a chronic stress rat model. PLoS ONE 2012; 7: (2), e31774.
29. Larauche M, Kiank C, Tache Y. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J Physiol Pharmacol 2009; 60: 33-46.
30. McCarthy JR, Heinrichs SC, Grigoriadis DE. Recent advances with the CRF(1) receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 1999; 5: 289-315.
31. Liu SM, Gao N, Hu, HZ, Wang X, Wang GD, Fang X, Gao X, Xia Y, Wood JD. Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system. J Comp Neurol 2006; 494: 63-74.
32. Yuan PQ, Million M, Wu SV, Rivier J, Tache Y. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin(1)-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 2007; 19: 923-36.
33. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heilbronn R, Herzog H, Sperk G. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 2010; 30: 6282-90.
34. Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res 1993; 18: 311-5.
35. Dimitrov EL, DeJoseph MR, Brownfield MS, Urban JH. Involvement of neuropeptide YY1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Endocrinology 2007; 148: 3666-73.
36. Heinrichs SC, Menzaghi F, Pich EM, Hauger RL, Koob GF. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by Neuropeptide Y. Brain Res 1993; 611: 18-24.
37. Painsipp E, Koefer MJ, Farzi A, Dischinger US, Sinner F, Herzog H, Holzer P. Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guerin in mice. Br J Pharmacol 2013; 170: 1014-26.